Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spyre Therapeutics (SYRE) Prepaid Assets (2016 - 2025)

Spyre Therapeutics' Prepaid Assets history spans 11 years, with the latest figure at $21.2 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 294.5% year-over-year to $21.2 million; the TTM value through Dec 2025 reached $21.2 million, up 294.5%, while the annual FY2025 figure was $21.2 million, 294.5% up from the prior year.
  • Prepaid Assets reached $21.2 million in Q4 2025 per SYRE's latest filing, up from $18.4 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $21.2 million in Q4 2025 to a low of $2.2 million in Q3 2023.
  • Average Prepaid Assets over 5 years is $7.0 million, with a median of $5.5 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: crashed 72.23% in 2023, then soared 294.5% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $4.9 million in 2021, then rose by 24.74% to $6.2 million in 2022, then plummeted by 63.53% to $2.3 million in 2023, then soared by 139.27% to $5.4 million in 2024, then skyrocketed by 294.5% to $21.2 million in 2025.
  • Per Business Quant, the three most recent readings for SYRE's Prepaid Assets are $21.2 million (Q4 2025), $18.4 million (Q3 2025), and $12.3 million (Q2 2025).